243 related articles for article (PubMed ID: 25650684)
1. The association between working alliance and clinical and functional outcome in a cohort of 400 patients with first-episode psychosis: a cross-sectional study.
Melau M; Harder S; Jeppesen P; Hjorthøj C; Jepsen JR; Thorup A; Nordentoft M
J Clin Psychiatry; 2015 Jan; 76(1):e83-90. PubMed ID: 25650684
[TBL] [Abstract][Full Text] [Related]
2. Negative, not positive symptoms predict the early therapeutic alliance in cognitive behavioral therapy for psychosis.
Jung E; Wiesjahn M; Lincoln TM
Psychother Res; 2014; 24(2):171-83. PubMed ID: 24219351
[TBL] [Abstract][Full Text] [Related]
3. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. Supportive psychodynamic psychotherapy versus treatment as usual for first-episode psychosis: two-year outcome.
Rosenbaum B; Harder S; Knudsen P; Køster A; Lindhardt A; Lajer M; Valbak K; Winther G
Psychiatry; 2012; 75(4):331-41. PubMed ID: 23244011
[TBL] [Abstract][Full Text] [Related]
6. Case manager- and patient-rated alliance as a predictor of medication adherence in first-episode psychosis.
Montreuil TC; Cassidy CM; Rabinovitch M; Pawliuk N; Schmitz N; Joober R; Malla AK
J Clin Psychopharmacol; 2012 Aug; 32(4):465-9. PubMed ID: 22722507
[TBL] [Abstract][Full Text] [Related]
7. Personality traits, interpersonal problems and therapeutic alliance in early schizophrenia spectrum disorders.
Johansen R; Melle I; Iversen VC; Hestad K
Compr Psychiatry; 2013 Nov; 54(8):1169-76. PubMed ID: 23856387
[TBL] [Abstract][Full Text] [Related]
8. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
9. Negative symptoms and poor insight as predictors of the similarity between client and therapist ratings of therapeutic alliance in cognitive behavior therapy for patients with schizophrenia.
Lysaker PH; Davis LW; Buck KD; Outcalt S; Ringer JM
J Nerv Ment Dis; 2011 Mar; 199(3):191-5. PubMed ID: 21346490
[TBL] [Abstract][Full Text] [Related]
10. The effect of working alliance on adherence and outcome in cognitive remediation therapy.
Huddy V; Reeder C; Kontis D; Wykes T; Stahl D
J Nerv Ment Dis; 2012 Jul; 200(7):614-9. PubMed ID: 22759940
[TBL] [Abstract][Full Text] [Related]
11. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study.
Peña J; Segarra R; Ojeda N; García J; Eguiluz JI; Gutiérrez M
J Psychiatr Res; 2012 Jun; 46(6):774-81. PubMed ID: 22487311
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.
Girón M; Fernández-Yañez A; Mañá-Alvarenga S; Molina-Habas A; Nolasco A; Gómez-Beneyto M
Psychol Med; 2010 Jan; 40(1):73-84. PubMed ID: 19490746
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
14. Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial.
Faber G; Smid HG; Van Gool AR; Wunderink L; van den Bosch RJ; Wiersma D
J Clin Psychiatry; 2012 May; 73(5):632-8. PubMed ID: 22394457
[TBL] [Abstract][Full Text] [Related]
15. Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia?
Couture SM; Roberts DL; Penn DL; Cather C; Otto MW; Goff D
J Nerv Ment Dis; 2006 Jan; 194(1):10-4. PubMed ID: 16462549
[TBL] [Abstract][Full Text] [Related]
16. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?
Wittorf A; Jakobi UE; Bannert KK; Bechdolf A; Müller BW; Sartory G; Wagner M; Wiedemann G; Wölwer W; Herrlich J; Buchkremer G; Klingberg S
J Nerv Ment Dis; 2010 Jul; 198(7):478-85. PubMed ID: 20611050
[TBL] [Abstract][Full Text] [Related]
17. Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis.
Lecomte T; Spidel A; Leclerc C; MacEwan GW; Greaves C; Bentall RP
Schizophr Res; 2008 Jul; 102(1-3):295-302. PubMed ID: 18295458
[TBL] [Abstract][Full Text] [Related]
18. Predictors of therapeutic alliance in early psychosis.
Bourdeau G; Théroux L; Lecomte T
Early Interv Psychiatry; 2009 Nov; 3(4):300-3. PubMed ID: 22642734
[TBL] [Abstract][Full Text] [Related]
19. Apathy and functioning in first-episode psychosis.
Faerden A; Friis S; Agartz I; Barrett EA; Nesvåg R; Finset A; Melle I
Psychiatr Serv; 2009 Nov; 60(11):1495-503. PubMed ID: 19880468
[TBL] [Abstract][Full Text] [Related]
20. Metacognition as a predictor of therapeutic alliance over 26 weeks of psychotherapy in schizophrenia.
Davis LW; Eicher AC; Lysaker PH
Schizophr Res; 2011 Jun; 129(1):85-90. PubMed ID: 21458241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
